Logo

Cira Discovery Sciences and Wistar Institute to Collaborate on Proteomics-Based Diagnostics

Feb 23, 2004

NEW YORK, Feb. 23 (GenomeWeb News) - Cira Discovery Sciences and researchers at The Wistar Institute will collaborate to develop diagnostic tests for cancer and lung disease, Cira said today.

 

Proteomics researchers at Wistar, led by David Speicher, will use Cira's computational methods to discover patterns in large proteomics data sets.

 

Cira, based in Philadelphia and founded last year, recently received a seed round of investment from BioAdvance.

 

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.